← FDA DRUG APPROVALS
FDA ANDA · ANDA215220
SITAGLIPTIN AND METFORMIN HYDROCHLORIDE
Sponsor: AJANTA PHARMA LTD
APPLICATION
ANDA215220
TYPE
ANDA
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
None (Tentative Approval)
Products
SITAGLIPTIN AND METFORMIN HYDROCHLORIDENone (Tentative Approval)
SITAGLIPTIN 50MG/1000MG, METFORMIN HYDROCHLORIDE · TABLET · ORAL
Approval history
2026-07-16UNKNOWN · Original · standardTA
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.